Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 28,600
-500 (-1.72%)
Apr 2, 2026, 3:30 PM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 168.17 billion as of April 2, 2026. Its market cap has increased by 12.82% in one year.
Market Cap
168.17B
Enterprise Value
78.65B
Revenue
208.61B
Ranking
n/a
PE Ratio
6.08
Stock Price
28,600.00
Market Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 168.17B, an increase of 655.47%. That is a compound annual growth rate of 8.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 168.17B | -2.22% |
| Dec 30, 2025 | 171.99B | 11.64% |
| Dec 30, 2024 | 154.06B | -5.59% |
| Dec 28, 2023 | 163.17B | -11.13% |
| Dec 29, 2022 | 183.60B | 6.62% |
| Dec 30, 2021 | 172.20B | -12.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 200.94B |
| JW Lifescience | 199.91B |
| Samil Pharmaceutical Co.,Ltd | 195.31B |
| Whan In Pharm | 194.64B |
| AptaBio Therapeutics | 193.84B |
| REYON Pharmaceutical | 184.14B |
| Kyongbo Pharmaceutical | 182.65B |
| SAMSUNG PHARM. Co., LTD. | 166.31B |